Jump Financial, LLC G1 Therapeutics, Inc. Transaction History

Jump Financial, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	SELL	$1.12 - $3.73 $79,503 - $264,774	-70,985 Reduced 67.36%	34,400 $104,000
Q4 2023 Feb 07, 2024	BUY	$1.12 - $3.73 $38,528 - $128,312	34,400 New	34,400 $104,000
Q2 2023 Oct 21, 2024	BUY	$2.46 - $3.14 $259,247 - $330,908	105,385 New	105,385 $262,000
Q2 2023 Aug 07, 2023	BUY	$2.46 - $3.14 $259,247 - $330,908	105,385 New	105,385 $262,000
Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $26,484 - $68,890	5,103 Added 12.92%	44,603 $242,000
Q3 2022 Nov 07, 2022	SELL	$5.17 - $16.99 $8,034 - $26,402	-1,554 Reduced 3.79%	39,500 $493,000
Q2 2022 Aug 09, 2022	BUY	$4.04 - $8.51 $165,858 - $349,369	41,054 New	41,054 $203,000
Q1 2022 May 12, 2022	SELL	$7.6 - $11.02 $147,440 - $213,788	-19,400 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$10.16 - $16.17 $197,104 - $313,698	19,400 New	19,400 $198,000
Q3 2021 Nov 12, 2021	SELL	$13.16 - $22.47 $446,150 - $761,777	-33,902 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $663,462 - $892,300	33,902 New	33,902 $744,000
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $342,052 - $634,929	-31,124 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$11.55 - $23.75 $359,482 - $739,195	31,124 New	31,124 $359,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.